Light Sky Macro’s Neuphoria Therapeutics NEUP Stock Holding History

Light Sky Macro’s Portfolio NEUP Stock Details NEUP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.34M	Sell	13,105 -3,159	-19%	-$416K	100%	1
2021 Q4	$2.45M	Buy	+16,264	New	+$2.49M	1.87%	7

Other funds holding NEUP

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Light Sky Macro's NEUP Position: Q1 2022 in Review

Light Sky Macro reduced its Neuphoria Therapeutics (NEUP) stake by 19% in Q1 2022, selling an estimated $416K and leaving 13,105 shares worth $1.34M. The position accounts for 100% of the portfolio, ranked #1.

Light Sky Macro first reported a position in NEUP in Q4 2021 and has held it in 2 quarters since. The position peaked at $2.45M in Q4 2021. 4 funds tracked by Wall St. Rank hold NEUP as of Q1 2022.

Light Sky Macro held 13,105 shares of Neuphoria Therapeutics worth $1.34M as of Q1 2022.
Light Sky Macro sold 3,159 Neuphoria Therapeutics shares in Q1 2022, an estimated $416K.
Neuphoria Therapeutics made up 100% of Light Sky Macro's portfolio in Q1 2022, its #1 holding.
Light Sky Macro first reported a position in Neuphoria Therapeutics in Q4 2021 and has held it in 2 quarters since.
Light Sky Macro's Neuphoria Therapeutics position peaked at $2.45M in Q4 2021.
4 funds tracked by Wall St. Rank held Neuphoria Therapeutics as of Q1 2022.

Based on Light Sky Macro's 13F filing for Q1 2022, filed 6 May 2022.